Accéder au contenu
Merck
  • Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation.

Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation.

Bioorganic & medicinal chemistry letters (2012-08-18)
Mettu Ravinder, Budde Mahendar, Saidulu Mattapally, Kommi Venkata Hamsini, Thatikonda Narendar Reddy, Chilappa Rohit, Kolupula Srinivas, Sanjay Kumar Banerjee, Vaidya Jayathirtha Rao
RÉSUMÉ

Twenty-six 2-pyridone derivatives (8a-8z), which are structurally analogous to amrinone and milrinone two important cardiotonic drugs, are synthesized and characterized. The synthesis of 2-pyridone derivatives involves addition, followed by cyclization between Baylis-Hillman acetates (7a-7k) and enamino esters or nitriles (3a-3e). Thus synthesized pyridones were subjected to PDE3 inhibitory activity, 14 pyridones were found to be hits out of 26 pyridones synthesized and out of 14 hits, there are 5 pyridones found to be lead compounds having excellent PDE3 inhibitory activity. Further we have carried out computational analysis to understand protein/enzyme and 2-pyridone derivative interactions to identify amino acid residues involved in the vicinity of binding and compared with milrinone drug.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Hydroxypyridine, 97%
Levetiracetam impurity C, European Pharmacopoeia (EP) Reference Standard